Categories: Entertainment

NYSE Content Advisory: Pre-Market Update + LA Times Media Group takes step towards trading debut

NEW YORK, Oct. 13, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on October 13th

- Advertisement -
  • The Los Angeles Times Media Group took a step towards trading on the NYSE last week. The group opened a private placement opportunity to be followed by a potential IPO.
  • Dr. Patrick Soon-Shiong, Chairman and CEO of the group, said at the NYSE that he plans to build a media company for the future.
  • Stocks are rebounding Monday morning after President Trump said trade relations with China “will all be fine.” Trump suggested on Sunday that he may not follow through on his threat of a massive increase of tariffs.
  • The U.S. government remains shut down, limiting the release of economic data. The bond market is closed today, although equity trading does resume on the NYSE.
  • The National Association of Corporate Directors convenes in Washington D.C today to strategize on tackling pressing issues facing companies.


Opening Bell

FactSet (NYSE: FDS) celebrates newly appointed CEO Sanoke Viswanathan

- Advertisement -


Closing Bell


Columbus Citizens Foundation rings the Opening Bell

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2794660/NYSE_Market_Update_Oct_13.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5558872/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–la-times-media-group-takes-step-towards-trading-debut-302582027.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

4 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago